<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01898637</url>
  </required_header>
  <id_info>
    <org_study_id>12-009527</org_study_id>
    <nct_id>NCT01898637</nct_id>
  </id_info>
  <brief_title>A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1</brief_title>
  <official_title>A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this project is to determine if the change in oxygen saturation during deep&#xD;
      inspiration (&quot;augmented pulse oximetry&quot;) can be used as a method to rule out pulmonary&#xD;
      embolism (PE). The investigators propose to evaluate a simple, non-invasive clinical tool to&#xD;
      help rule out PE. The investigators plan to measure the oxygen saturation of 40 consecutive&#xD;
      patients with newly-diagnosed PE (within 60 minutes of diagnosis) and 80 matched controls who&#xD;
      do not have a PE. Trained, blinded Respiratory Therapists or Study Coordinators will record&#xD;
      each patient's oxygen saturation before, during, and after a 2-minute period of deep&#xD;
      inspirations (vital capacity [the maximal amount of air that can be inhaled, measured in&#xD;
      milliliters]) using an incentive spirometer. The investigators' central hypothesis is that&#xD;
      persons with a PE will not respond to augmented pulse oximetry and will not significantly&#xD;
      improve or normalize their oxygen saturation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be identified and enrolled by the Mayo Clinic St. Marys Emergency Department&#xD;
      staff as they are undergoing medical care in the Emergency Department.&#xD;
&#xD;
      The investigators will calculate the difference in oxygen saturation pre- and post-deep&#xD;
      inspiration (ΔSpO2 at 1 minute, 2 minutes and 4 minutes), and then correlate these values&#xD;
      with the CT result.&#xD;
&#xD;
      In cases of PE, The investigators expect the SpO2 to remain unchanged, or to change less than&#xD;
      3-5%. The investigators expect alternate hypoxemic conditions to have a significantly greater&#xD;
      increase in SpO2.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in oxygen saturation using augmented pulse oximetry for patients with and without pulmonary embolism.</measure>
    <time_frame>Oxygen saturation (SpO2) will be recorded prior to using the spirometer, at 1 minute (during use of the spirometer), at 2 minutes (at the end of using the spirometer), and at 4 minutes.</time_frame>
    <description>Trained, blinded Respiratory Therapists or Study Coordinators will record each patient's oxygen saturation before, during, and after a 2-minute period of deep inspirations (vital capacity) using an incentive spirometer. The investigators will calculate the difference in oxygen saturation pre- and post-deep inspiration (ΔSpO2 at 1 minute, 2 minutes and 4 minutes), and then correlate these values with the CT result.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vital capacity (the maximal amount of air that can be inhaled, measured in milliliters) during augmented pulse oximetry.</measure>
    <time_frame>The single maximum value obtained before, during, or after use of the incentive spirometer.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Proven pulmonary embolism.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Augmented pulse oximetry using incentive spirometer. Emergency Department patients with pulmonary embolism.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Augmented pulse oximetry using incentive spirometer. Emergency Department patients who do not have pulmonary embolism.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Augmented pulse oximetry using incentive spirometer.</intervention_name>
    <description>Augmented pulse oximetry using incentive spirometer.</description>
    <arm_group_label>Control patients</arm_group_label>
    <arm_group_label>Proven pulmonary embolism.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Incentive spirometer.</intervention_name>
    <description>The incentive spirometer is a simple passive device that measures the amount of air a person can inhale.</description>
    <arm_group_label>Control patients</arm_group_label>
    <arm_group_label>Proven pulmonary embolism.</arm_group_label>
    <other_name>AirLife Volumetric Incentive Spirometer.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or greater.&#xD;
&#xD;
          -  Agrees and able to participate in the study.&#xD;
&#xD;
          -  Room air SpO2 (oxygen saturation) less than 92% and newly-diagnosed PE (or controls&#xD;
             with no PE) based on CT angiogram result.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical concern for instability.&#xD;
&#xD;
          -  Systolic blood pressure less than 100 mm Hg.&#xD;
&#xD;
          -  Heart rate ≥140 beats per minute.&#xD;
&#xD;
          -  Oxygen saturation less than 85% with more than 4 L supplemental oxygen.&#xD;
&#xD;
          -  Unable to participate/comply with instructions for using the incentive spirometer.&#xD;
&#xD;
          -  Patients from the Federal Medical Center in Rochester, Minnesota.&#xD;
&#xD;
          -  Patients who do not speak English (due to the need for expediency).&#xD;
&#xD;
        Patients will be under the care of the Emergency Department team who have the skills and&#xD;
        resources to monitor and treat patients if they were to become unstable.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A. S. Keller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 28, 2013</study_first_submitted>
  <study_first_submitted_qc>July 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2013</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Scott Keller</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>pulmonary embolism</keyword>
  <keyword>pulse oximetry</keyword>
  <keyword>change in oxygen saturation</keyword>
  <keyword>hypoxemia</keyword>
  <keyword>emergency department</keyword>
  <keyword>deep inspiration</keyword>
  <keyword>vital capacity</keyword>
  <keyword>clinical diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

